• About us
• Contact

Advertisement

Organisation › Details

Biogen Idec (Group)

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients worldwide benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. *

 

	Start	2003-11-12 merged
	End	2015-03-23 renamed
	Group	Biogen (Group)
	Today	Biogen (Group)
	Successor	Biogen (Group)
	Industry	pharmaceutical
	Street	133 Boston Post Road
	City	02493 Weston, MA
	Tel	+1-781-464-2000
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for Biogen (Group)

• [1] European Pharma Oligonucleotide Consortium (EPOC). (1/25/19). Web Site: European Pharma Oligonucleotide Consortium [incl. EPOC Presenation by Roche Orr, 8 November 2018, at EuroTides]. [www.epoconsortium.com, 01/25/19]...

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.